コロラド州における潰瘍性大腸炎の臨床試験
コロラド州内の拠点で、潰瘍性大腸炎に関する17件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Peak Gastroenterology Associates, Colorado Springs
- Rocky Mountain Endocopy Centers LLC, Littleton
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 033, Colorado Springs
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Peak Gastroenterology Associates ( Site 1052), Colorado Springs
- South Denver Gastroenterology, PC ( Site 1068), Englewood
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- South Denver Gastroenterology, Englewood
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Peak Gastroenterology Associates, Colorado Springs
- Rocky Mountain Gastroenterology Associates - Lakewood, Lakewood
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Peak Gastroenterology Associates, Colorado Springs
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UCHealth Digestive Health Center - Anschutz Medical Campus - Site Number: 8400085, Aurora
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
- Gastroenterology of the Rockies - Denver - Site Number: 8400122, Denver
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Colorado, Aurora
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Rocky Mountain Gastroenterology, Littleton
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Colorado Springs
- Mirador Therapeutics Selected Site, Littleton
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。